Published in Biochem Biophys Res Commun on March 11, 2010
Crystal structures of β-1,4-galactosyltransferase 7 enzyme reveal conformational changes and substrate binding. J Biol Chem (2013) 0.82
Cellular disulfide bond formation in bioactive peptides and proteins. Int J Mol Sci (2015) 0.78
The N-acetyl-binding pocket of N-acetylglucosaminyltransferases also accommodates a sugar analog with a chemical handle at C2. Glycobiology (2011) 0.77
Expression of Functional Human Sialyltransferases ST3Gal1 and ST6Gal1 in Escherichia coli. PLoS One (2016) 0.76
Antigenicity of recombinant maltose binding protein-Mycobacterium avium subsp. paratuberculosis fusion proteins with and without factor Xa cleaving. Clin Vaccine Immunol (2013) 0.75
A fusion protein strategy for soluble expression of Stevia glycosyltransferase UGT76G1 in Escherichia coli. 3 Biotech (2017) 0.75
The Cationminus signpi Interaction. Chem Rev (1997) 7.56
Cation-pi interactions in structural biology. Proc Natl Acad Sci U S A (1999) 6.88
Galectins as modulators of tumour progression. Nat Rev Cancer (2005) 5.30
Recombinant protein folding and misfolding in Escherichia coli. Nat Biotechnol (2004) 4.47
Specificities of heparan sulphate proteoglycans in developmental processes. Nature (2000) 3.46
Advanced genetic strategies for recombinant protein expression in Escherichia coli. J Biotechnol (2005) 3.29
Galectin-1: a small protein with major functions. Glycobiology (2006) 3.06
Introduction to galectins. Glycoconj J (2004) 2.30
Intracellular functions of galectins. Biochim Biophys Acta (2002) 2.29
Roles of galectins in infection. Nat Rev Microbiol (2009) 2.25
Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies. Mol Cell Biochem (2007) 2.03
Enhancement of soluble protein expression through the use of fusion tags. Curr Opin Biotechnol (2006) 2.02
Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens. J Biol Chem (2008) 2.02
SUMO fusion technology for difficult-to-express proteins. Protein Expr Purif (2005) 1.89
Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding. J Mol Biol (2004) 1.57
The solubility and stability of recombinant proteins are increased by their fusion to NusA. Biochem Biophys Res Commun (2004) 1.45
Galectin-1 as a potential cancer target. Br J Cancer (2005) 1.45
Carbohydrate-pi interactions: what are they worth? J Am Chem Soc (2008) 1.41
The galactosyltransferase family. Cell Mol Life Sci (2002) 1.39
Cloning and expression of a proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I. A seventh member of the human beta4-galactosyltransferase gene family. J Biol Chem (1999) 1.37
A novel missense mutation in the galactosyltransferase-I (B4GALT7) gene in a family exhibiting facioskeletal anomalies and Ehlers-Danlos syndrome resembling the progeroid type. Am J Med Genet A (2004) 1.34
A generic protocol for the expression and purification of recombinant proteins in Escherichia coli using a combinatorial His6-maltose binding protein fusion tag. Nat Protoc (2007) 1.25
Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodies. J Mol Biol (2001) 1.24
Structure and catalytic cycle of beta-1,4-galactosyltransferase. Curr Opin Struct Biol (2004) 1.09
Learning about protein solubility from bacterial inclusion bodies. Microb Cell Fact (2009) 1.09
Mutations that alter the equilibrium between open and closed conformations of Escherichia coli maltose-binding protein impede its ability to enhance the solubility of passenger proteins. Biochem Biophys Res Commun (2007) 1.00
The N-terminal stem region of bovine and human beta1,4-galactosyltransferase I increases the in vitro folding efficiency of their catalytic domain from inclusion bodies. Protein Expr Purif (2003) 0.98
Functional and structural bases of a cysteine-less mutant as a long-lasting substitute for galectin-1. Glycobiology (2008) 0.97
Studies on the metal binding sites in the catalytic domain of beta1,4-galactosyltransferase. Glycobiology (2002) 0.91
Thermodynamic insights into the structural basis governing the donor substrate recognition by human beta1,4-galactosyltransferase 7. Biochem J (2009) 0.83
Interference of the galactose-dependent binding of lectins by novel pentapeptide ligands. Bioorg Med Chem Lett (2004) 0.81
Galectin-1-asialofetuin interaction is inhibited by peptides containing the tyr-xxx-tyr motif acting on the glycoprotein. Chembiochem (2010) 0.77
A chemoenzymatic approach toward the rapid and sensitive detection of O-GlcNAc posttranslational modifications. J Am Chem Soc (2003) 2.14
Substrate-induced conformational changes in glycosyltransferases. Trends Biochem Sci (2005) 1.73
Structure-based design of beta 1,4-galactosyltransferase I (beta 4Gal-T1) with equally efficient N-acetylgalactosaminyltransferase activity: point mutation broadens beta 4Gal-T1 donor specificity. J Biol Chem (2002) 1.66
Structure and function of beta -1,4-galactosyltransferase. Curr Drug Targets (2008) 1.20
Crystal structure of beta1,4-galactosyltransferase complex with UDP-Gal reveals an oligosaccharide acceptor binding site. J Mol Biol (2002) 1.14
Structural snapshots of beta-1,4-galactosyltransferase-I along the kinetic pathway. J Mol Biol (2006) 1.13
Direct identification of nonreducing GlcNAc residues on N-glycans of glycoproteins using a novel chemoenzymatic method. Bioconjug Chem (2007) 1.11
Structure and catalytic cycle of beta-1,4-galactosyltransferase. Curr Opin Struct Biol (2004) 1.09
Site specific conjugation of fluoroprobes to the remodeled Fc N-glycans of monoclonal antibodies using mutant glycosyltransferases: application for cell surface antigen detection. Bioconjug Chem (2009) 1.08
The N-terminal stem region of bovine and human beta1,4-galactosyltransferase I increases the in vitro folding efficiency of their catalytic domain from inclusion bodies. Protein Expr Purif (2003) 0.98
Novel method for in vitro O-glycosylation of proteins: application for bioconjugation. Bioconjug Chem (2007) 0.97
Deoxygenated disaccharide analogs as specific inhibitors of beta1-4-galactosyltransferase 1 and selectin-mediated tumor metastasis. J Biol Chem (2008) 0.96
Site-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugar. MAbs (2014) 0.96
Iterative cluster-NMA: A tool for generating conformational transitions in proteins. Proteins (2009) 0.93
Role of a single amino acid in the evolution of glycans of invertebrates and vertebrates. J Mol Biol (2006) 0.93
Studies on the metal binding sites in the catalytic domain of beta1,4-galactosyltransferase. Glycobiology (2002) 0.91
Effect of the Met344His mutation on the conformational dynamics of bovine beta-1,4-galactosyltransferase: crystal structure of the Met344His mutant in complex with chitobiose. Biochemistry (2004) 0.90
Site-specific linking of biomolecules via glycan residues using glycosyltransferases. Biotechnol Prog (2008) 0.89
Mutation of arginine 228 to lysine enhances the glucosyltransferase activity of bovine beta-1,4-galactosyltransferase I. Biochemistry (2005) 0.89
Interdependence of backbone flexibility, residue conservation, and enzyme function: a case study on beta1,4-galactosyltransferase-I. Biochemistry (2003) 0.86
Crystal structure of the catalytic domain of Drosophila beta1,4-Galactosyltransferase-7. J Biol Chem (2010) 0.86
The role of tryptophan 314 in the conformational changes of beta1,4-galactosyltransferase-I. J Mol Biol (2003) 0.85
Bioconjugation and detection of lactosamine moiety using alpha1,3-galactosyltransferase mutants that transfer C2-modified galactose with a chemical handle. Bioconjug Chem (2009) 0.84
Multiple site-specific in vitro labeling of single-chain antibody. Bioconjug Chem (2009) 0.83
Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRI. AAPS J (2006) 0.83
Crystal structures of β-1,4-galactosyltransferase 7 enzyme reveal conformational changes and substrate binding. J Biol Chem (2013) 0.82
Beta-1,4-galactosyltransferase and lactose synthase: molecular mechanical devices. Biochem Biophys Res Commun (2002) 0.81
Letter to the Glyco-Forum: catalytic domains of glycosyltransferases with 'add-on' domains. Glycobiology (2007) 0.80
Structure-based evolutionary relationship of glycosyltransferases: a case study of vertebrate β1,4-galactosyltransferase, invertebrate β1,4-N-acetylgalactosaminyltransferase and α-polypeptidyl-N-acetylgalactosaminyltransferase. Curr Opin Struct Biol (2010) 0.80
Use of novel mutant galactosyltransferase for the bioconjugation of terminal N-acetylglucosamine (GlcNAc) residues on live cell surface. Bioconjug Chem (2013) 0.80
Improved synthesis of UDP-2-(2-ketopropyl)galactose and a first synthesis of UDP-2-(2-ketopropyl)glucose for the site-specific linking of biomolecules via modified glycan residues using glycosyltransferases. Tetrahedron (2011) 0.79
Applications of glycosyltransferases in the site-specific conjugation of biomolecules and the development of a targeted drug delivery system and contrast agents for MRI. Expert Opin Drug Deliv (2008) 0.79
Binding of N-acetylglucosamine (GlcNAc) β1-6-branched oligosaccharide acceptors to β4-galactosyltransferase I reveals a new ligand binding mode. J Biol Chem (2012) 0.78
Comparison of the closed conformation of the beta 1,4-galactosyltransferase-1 (beta 4Gal-T1) in the presence and absence of alpha-lactalbumin (LA). J Biomol Struct Dyn (2003) 0.77
The N-acetyl-binding pocket of N-acetylglucosaminyltransferases also accommodates a sugar analog with a chemical handle at C2. Glycobiology (2011) 0.77
Bioconjugation using mutant glycosyltransferases for the site-specific labeling of biomolecules with sugars carrying chemical handles. Methods Mol Biol (2011) 0.77
Applications of site-specific labeling to study HAMLET, a tumoricidal complex of α-lactalbumin and oleic acid. PLoS One (2011) 0.77
Correction to Glycans of Antibodies as a Specific Site for Drug Conjugation Using Glycosyltransferases. Bioconjug Chem (2015) 0.75
Investigations on β1,4-galactosyltransferase I using 6-sulfo-GlcNAc as an acceptor sugar substrate. Glycoconj J (2013) 0.75
In vitro folding of β-1,4galactosyltransferase and polypeptide-α-N-acetylgalactosaminyltransferase from the inclusion bodies. Methods Mol Biol (2013) 0.75